BioXCel Therapeutics
![Missed trial procedures, made-up emails, and an unsuccessful endpoint make a mess Alzheimer's agitation readout from BioXCel | Pharmtales](https://pharmtales.com/wp-content/uploads/2023/07/Missed-trial-procedures-made-up-emails-and-an-unsuccessful-endpoint-make-a-mess-Alzheimers-agitation-readout-from-BioXCel.jpg)
Missed trial procedures, made-up emails, and an unsuccessful endpoint make a mess Alzheimer’s agitation readout from BioXCel
SG Tylor
Source – BioXcel Therapeutics On June 29, 2023, a potential breakthrough in the treatment of agitation episodes in Alzheimer’s disease ...